Latest filing published 06 Jun 2024 for Biora Therapeutics, INC.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of Jeffrey D. Alter across 2 companies, led by Biora Therapeutics, Inc. and Elevance Health, Inc. Between 14 June 2021 and 5 June 2024, the trades on record add up to 6 filings.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The latest filing, published on 6 June 2024, reports a share grant in Biora Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations